Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.42%
1,087.39
+4.59
+0.42%
1,082.801,079.311,090.181,079.31
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
610.18
+6.41
+1.06%
603.77603.77611.65602.09
SIXE
Energy
SIXE
Energy
SIXE
-1.14%
1,197.43
-13.76
-1.14%
1,211.191,203.051,203.481,182.72
SIXI
Industrials
SIXI
Industrials
SIXI
+0.21%
1,759.64
+3.65
+0.21%
1,755.991,759.061,761.311,747.23
SIXM
Financials
SIXM
Financials
SIXM
-0.82%
633.26
-5.25
-0.82%
638.51637.93640.10631.89
SIXR
Staples
SIXR
Staples
SIXR
+1.34%
854.29
+11.33
+1.34%
842.96843.54858.44843.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.01%
219.26
-0.020
-0.01%
219.28219.28220.58218.64
SIXT
Technology
SIXT
Technology
SIXT
-0.46%
3,711.29
-17.06
-0.46%
3,728.353,745.063,745.063,675.02
SIXU
Utilities
SIXU
Utilities
SIXU
-0.55%
910.42
-5.06
-0.55%
915.48914.49915.84907.90
SIXV
Health care
SIXV
Health care
SIXV
+0.09%
1,498.73
+1.37
+0.09%
1,497.361,500.651,514.701,495.89
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.44%
2,447.86
+34.69
+1.44%
2,413.172,431.692,463.522,431.69
ANVS:NYSE
Annovis Bio Inc
$2.00
-2.68%
(-0.055) 1D
May 27, 2:47:28 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
$2.05
High
$2.12
Low
$1.98
Mkt. cap
69.64M
Avg. vol.
1.18M
Volume
898.41K
52-wk high
$5.50
52-wk low
$1.54
EPS
-$1.70
Beta
1.26
Shares outstanding
34.65M
No. of employees
8
News stories
From sources across the web
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Last report
May 15, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.63 / -$0.36
-75.00%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.16M
6.29M
8.75M
16.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.11M
1.14M
955.15K
1.29M
Operating expense
6.27M
7.43M
9.71M
18.01M
Total operating expenses
6.27M
7.43M
9.71M
18.01M
Operating income
-6.27M
-7.43M
-9.71M
-18.01M
Other non operating income
-140.00K
20.00K
-296.00K
268.00K
EBT including unusual items
-6.22M
-7.26M
-9.83M
-17.61M
EBT excluding unusual items
-6.22M
-7.26M
-9.83M
-17.61M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.22M
-7.26M
-9.83M
-17.61M
Net profit margin
-
-
-
-
Earnings per share
-0.32
-0.37
-0.39
-0.63
Interest and investment income
191.40K
152.32K
167.74K
137.80K
Interest expense
-
-
-
-
Net interest expenses
191.40K
152.32K
167.74K
137.80K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more